Breaking News
December 16, 2018 - Social stigma contributes to poor mental health in the autistic community
December 16, 2018 - Multidisciplinary team successfully performs complex surgery on patient suffering from enlarged skull
December 16, 2018 - Experts analyze data that can guide antidepressant discontinuation
December 16, 2018 - Menlo Therapeutics’ Successful Phase 2 Clinical Trial of Serlopitant Demonstrates Reduction of Pruritus Associated with Psoriasis
December 16, 2018 - Siblings of children with autism or ADHD are at elevated risk for both disorders
December 16, 2018 - New project aims to understand why and how metabolic disorders develop in patients
December 16, 2018 - Diets containing GM maize have no harmful effects on health or metabolism of rats
December 16, 2018 - Are doctors and teachers confusing immaturity and attention deficit?
December 16, 2018 - Hearing loss linked with increased risk for premature death
December 16, 2018 - Chromatrap buffer reagents for lysing cells offer many benefits
December 16, 2018 - Young Breast Cancer Patients Face Higher Risk for Osteoporosis
December 16, 2018 - 3-D printing offers helping hand to people with arthritis
December 16, 2018 - Community Health Choice helps manage complex and chronic care conditions
December 16, 2018 - Regular trips out could dramatically reduce depression in older age
December 16, 2018 - CWRU to use VivaLNK’s Vital Scout device for stress study in student athletes
December 16, 2018 - ‘Easy Way Out’? Stigma May Keep Many From Weight Loss Surgery
December 16, 2018 - Gout drug may protect against chronic kidney disease
December 16, 2018 - Talking about memories enhances the wellbeing of older and younger people
December 16, 2018 - Occupational exposure to pesticides increases risk for cardiovascular disease among Latinos
December 16, 2018 - A biomarker in the brain’s circulation system may be Alzheimer’s earliest warning
December 16, 2018 - Magnesium may play important role in optimizing vitamin D levels, study shows
December 16, 2018 - The effect of probiotics on intestinal flora of premature babies
December 16, 2018 - Parents spend more time talking with kids about mechanics of using mobile devices
December 16, 2018 - Biohaven Announces Positive Results from Ongoing Rimegepant Long-Term Safety Study
December 16, 2018 - Arterial stiffness may predict dementia risk
December 16, 2018 - Study explores link between work stress and increased cancer risk
December 16, 2018 - Sex work criminalization linked to incidences of violence finds study
December 16, 2018 - Johns Hopkins researchers discover swarming behavior in fish-dwelling parasite
December 16, 2018 - Schistosomiasis prevention and treatment could help control HIV
December 16, 2018 - Early postpartum opioids linked with persistent usage
December 16, 2018 - Johns Hopkins researchers identify molecular causes of necrotizing enterocolitis in preemies
December 16, 2018 - Advanced illumination expands capabilities of light-sheet microscopy
December 16, 2018 - Alzheimer’s could possibly be spread via contaminated neurosurgery
December 16, 2018 - Unraveling the complexity of cancer biology can prompt new avenues for drug development
December 16, 2018 - Inflammatory Bowel Disease, Prostate Cancer Linked
December 16, 2018 - Cannabis youth prevention strategy should target mental wellbeing
December 15, 2018 - Recent developments and challenges in hMAT inhibitors
December 15, 2018 - Sewage bacteria found lurking in Hudson River sediments
December 15, 2018 - CDC selects UMass Amherst biostatistician model that helps predict influenza outbreaks
December 15, 2018 - Researchers reveal brain mechanism that drives itch-evoked scratching behavior
December 15, 2018 - New computer model helps predict course of the disease in prostate cancer patients
December 15, 2018 - Obesity to Blame for Almost 1 in 25 Cancers Worldwide
December 15, 2018 - How the brain tells you to scratch that itch
December 15, 2018 - New findings could help develop new immunotherapies against cancer
December 15, 2018 - World’s largest AI-powered medical research network launched by OWKIN
December 15, 2018 - Young people suffering chronic pain battle isolation and stigma as they struggle to forge their identities
December 15, 2018 - Lifespan extension at low temperatures depends on individual’s genes, study shows
December 15, 2018 - New ingestible capsule can be controlled using Bluetooth wireless technology
December 15, 2018 - Researchers uncover microRNAs involved in the control of social behavior
December 15, 2018 - Research offers hope for patients with serious bone marrow cancer
December 15, 2018 - Link between poverty and obesity is only about 30 years old, study shows
December 15, 2018 - Mass spectrometry throws light on old case of intentional heavy metal poisoning
December 15, 2018 - BeyondSpring Announces Phase 3 Study 105 of its Lead Asset Plinabulin for Chemotherapy-Induced Neutropenia Meets Primary Endpoint at Interim Analysis
December 15, 2018 - Study finds that in treating obesity, one size does not fit all
December 15, 2018 - Tenacity and flexibility help maintain psychological well-being, mobility in older people
December 15, 2018 - Study reveals role of brain mechanism in memory recall
December 15, 2018 - High levels of oxygen encourage the brain to remain in deep, restorative sleep
December 15, 2018 - Experimental HIV vaccine strategy works in non-human primates, research shows
December 15, 2018 - Genetically modified pigs could limit replication of classical swine fever virus, study shows
December 15, 2018 - FDA Approves Herzuma (trastuzumab-pkrb), a Biosimilar to Herceptin
December 15, 2018 - Cost and weight-loss potential matter most to bariatric surgery patients
December 15, 2018 - Cancer Research UK and AstraZeneca open new Functional Genomics Centre
December 15, 2018 - New research lays out potential path for treatment of Huntington’s disease
December 15, 2018 - Prestigious R&D 100 Award presented to Leica Microsystems
December 15, 2018 - Study shows septin proteins detect and kill gut pathogen, Shigella
December 15, 2018 - Study sheds new light on disease-spreading mosquitoes
December 15, 2018 - 2017 Saw Slowing in National Health Care Spending
December 15, 2018 - Monitoring movement reflects efficacy of mandibular splint
December 15, 2018 - Study supports BMI as useful tool for assessing obesity and health
December 15, 2018 - Self-guided, internet-based therapy platforms effectively reduce depression
December 15, 2018 - Organically farmed food has bigger climate impact than conventional food production
December 15, 2018 - Faster, cheaper test has potential to enhance prostate cancer evaluation
December 15, 2018 - Researchers study abnormal blood glucose levels of patients after hospital discharge
December 15, 2018 - Swedish scientists explore direct association of dementia and ischemic stroke deaths
December 15, 2018 - Study finds 117% increase in number of dementia sufferers in 26 years
December 15, 2018 - Eczema Can Drive People to Thoughts of Suicide: Study
December 15, 2018 - Link between neonatal vitamin D deficiency and schizophrenia confirmed
December 15, 2018 - Nurse denied life insurance because she carries naloxone
December 15, 2018 - Ritalin drug affects organization of pathways that build brain networks used in attention, learning
December 15, 2018 - Research pinpoints two proteins involved in creation of stem cells
New partnership to evaluate effectiveness of diagnostic blood test for type 2 diabetes

New partnership to evaluate effectiveness of diagnostic blood test for type 2 diabetes

image_pdfDownload PDFimage_print

A new partnership in Leeds has been agreed to evaluate the benefits of a diagnostic blood test which can help predict whether someone is likely to develop type 2 diabetes.

The test, developed by US biotech company SomaLogic, measures protein indicators or biomarkers in a blood sample.

If the test is effective, it will enable GPs to work with their patients to find the best way to keep them healthy or to steer them towards better health.

The Leeds Centre for Personalized Medicine and Health will be working with SomaLogic to explore how to assess the effectiveness of the test through a number of clinical studies across the city, to see if it can be used to try and prevent cases of type 2 diabetes.

Figures from Public Health England (PHE) estimate that 3.8 million people have diabetes, nine out of ten having type 2 which PHE says is largely preventable or manageable through lifestyle changes, and prevalence of the condition is due to carry on increasing.

One of the key risk factors is being overweight.

It has been estimated that the cost of treating diabetes and its complications now accounts for ten percent of the NHS budget. PHE says tackling the disease is fundamental to the sustainable future of the NHS.

The SomaLogic test is based on proteomics where the levels of 5,000 specific proteins are measured to calculate the risks that an individual will develop certain conditions, such as heart disease, cancer or diabetes. The first phase of the partnership, which has been supported by the Yorkshire and Humber Academic Health Science Network, will focus on the effectiveness of the test in health initiatives designed to prevent type 2 diabetes.

What does this partnership mean for Leeds?

At the moment, people are assessed as being at high risk of type-2 diabetes if they have a raised level of a biomarker called HbA1c. Those people are offered regular screening and support on possible lifestyle changes.

However measuring HbA1c is not foolproof at predicting whether someone will go on and develop the condition.

SomaLogic’s test

Studies suggest that SomaLogic’s test could be more accurate at predicting if an individual will develop the condition, allowing GPs to better target and tailor interventions at those patients at the greatest risk.

Dr Mike Messenger, Head of the Leeds Centre for Personalized Medicine and Health, said:

For a number of years, doctors have spoken of personalized medicine – a move away from ‘one size fits all’ to a process of tailoring treatment using biomarkers, as SomaLogic is suggesting. Doing so would identify the right intervention for the right patient at the right time.

A greater understanding of individuals’ current and future health needs means GPs can provide the most effective advice to stay healthy. In some cases the evidence may point to more regular monitoring of a patient or advice about lifestyle changes; for others, it might mean medication or treatment at an earlier stage.

This is important research which could help to improve the health of people across Leeds for years to come.

Dr Steve Williams, Chief Medical Officer at SomaLogic, said:

This application of a personalized and comprehensive decoding of protein signals will enable people to assess their underlying biology to enhance health decisions by addressing the fundamentals of: ‘how much should I be concerned’ and ‘what should I do about it’.

The Leeds Centre for Personalized Medicine and Health is hosted by the University of Leeds and is part of the Leeds Academic Health Partnership, which brings together leading expertise from core partners including three of the city’s universities, NHS organizations and Leeds City Council. The Partnership identifies, attracts and implements innovation and inward investment that responds to the challenges facing health and care, including reducing health inequalities across the city.  

A city-wide partnership to try and prevent ill health

Dr Bryan Power, Long Term Conditions Clinical Lead, NHS Leeds Clinical Commissioning Groups Partnership says:

The proposed study offers Leeds citizens the opportunity to have an enhanced profiling and an understanding about their individual risk of developing specific diseases later in life and the underlying factors driving the risk. This resulting intelligence will enable individuals and clinicians to make changes to lifestyle and treatment to modify and reduce the risk of developing those conditions.

Dr Yvette Oade, Chief Medical Officer for Leeds Teaching Hospitals NHS Trust, said:

Research and innovation is at the heart of everything we do in Leeds Teaching Hospitals as we know it brings better outcomes for patients. Personalized medicine is an area of growth and this innovation which might allow us to understand the potential to predict and even prevent disease before it occurs is particularly exciting.

Councillor Rebecca Charlwood, chair of Leeds health and wellbeing board, said:

Our partnership with local Universities and the NHS is based on a strong commitment to early intervention and prevention, and stopping diseases from starting in the first place. We are committed to using innovative technologies to improve outcomes, particularly in our poorest communities where type 2 diabetes has the greatest impact. This trial could help us develop a more personalized approach that we hope will improve the lives of many people at risk of type II diabetes

Source:

http://www.leeds.ac.uk/news/article/4179/biotech_partnership_to_tackle_disease_before_it_starts

Tagged with:

About author

Related Articles